Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You can have a greatest product in the world but without effective marketing strategies it's a failure. What kind of marketing strategies are presently in place??
T2 is a rapid qualitative test with over 90% specificity that identifies Genus and Species within hours. There is nothing that comes even close.
Looks like MM dropped it to the .40's so short friends can cover.
Barry Kostiner, CEO of SAGA commented, "We are working together with the Enzolytics team to structure our transaction to give the Enzolytics shareholders the benefits of our Nasdaq listing, while also protecting their interests, given the current volatility in financial markets. Additionally, we are committed to working together to facilitate continued liquidity and provide the capital needed to properly fund the Enzolytics technology that has already demonstrated tremendous promise."
New business model for ENZC
That's what it looks like imo. Very disruptive at that.
Spot on.
This is the summary of the Phase III Bulgarian Trials~
Summarizing the results from the present clinical trial, we can draw the following conclusions:
1. The application of the product ITV-1-lmmunH shows good efficacy in patients with HIV-1 infection in its
various stages - in 21 of them (68%) from the main group we note an increase in CD4 + T- lymphocytes; in 16 of them
the increase is accompanied by an increase in the index CD4/CD8 and CD4%, which corresponds to a reduction in the
immune activation. The increase in these parameters is statistically significant compared to the control group. The
absolute number and the relative share of C08 + T lymphocytes is decreasing, too.
2. We observe a very good virological effect – the viral load in 80.5% of the patients is below the threshold of
detection (however, we have no comparison to the control group).
3. The application of the product ITV-1-lmmunH is well tolerated - only one patient manifested allergic dermal
response. With regard to none of them we found variations in the hematological and biochemical parameters,
neither did we establish clinically significant abnormal vital signs.
The Report was prepared by Assoc. Prof. Dr. Ivaylo Elenkov, MD, Chief researcher.
Dated: 23.11.2016
ITV-1 Bulgarian Phase III Trials~
Dec. 23 2016-(Extracted)
"We observe a very good virological effect – the viral load in 80.5% of the patients is below the threshold of detection."
Today's PR ~
We EXPECT the ... SAME RESULTS as the BULGARIAN TRIALS
Patients were Stage II, III and late stage IV! Go ENZC
We are golden.
How can two walk together except they agree?
Sheesh! Rather than becoming "toast", Enzolytics will have “Continued Liquidity”
Barry Kostiner, CEO of SAGA commented, "We are working together with the Enzolytics team to structure our transaction to give the Enzolytics shareholders the benefits of our Nasdaq listing, while also protecting their interests, given the current volatility in financial markets. Additionally, we are committed to working together to facilitate CONTINUED LIQUIDITY and provide the capital needed to properly fund the Enzolytics technology that has already demonstrated tremendous promise."
Is Enzolytics Discord channel shut down??
Looks to me they saw pps going way over the upper Bollinger band line and decided to bring it down to the line before it could get away from them.
I have read this study on the Rosetta web sight describing the action of IPF on tumor cells ~"IPF also binds to specific tumor antigens, making them recognizable to the immune system. Attached peptide chains to tumor antigens form super antigens that increase the production of antibodies against tumor cells and induce a specific T-lymphocyte response against tumor cells. An increase in CD4 + and an improvement in CD4 + / CD8 + T lymphocyte ratio were observed. Through its mechanism of action, IPF creates non-specific immunity over time."
Seal and stopper are intact
METHOD
Visual inspection
Copyright 2023 © Rosetta Lifecare Bulgaria LTD
My order with E-Trade won't go through on the ask. What's up, anybody??
Some people will say anything to try to make the price go down .
Regeneron already said trials will begin "later this year". In the meantime, I would expect PRs of IPF moving forward with Walmart and perhaps other online sites. Then uplist announcement somewhere along the way. By late March or April we should be hearing more ITV-1 updates. I would think there are going to be many progress reports from now on. ENZC has switched from promise PRs to progress PRs. Although we cannot see a monumental shift in pps, it looks like it is in the state of metamorphosis. GLTA
I have three other tickers at zero trades also as we speak.
I could not in good conscience be associated with this evil company regardless of share price.
Somebody is itching for cheaper shares. Lol
Bomo backed up to the 1 yard line. Broncos sacked BOMO in the end zone for a safety. End of game.
Go to Enzolytics.com(not Enzolytics therapeutics). On the pull down menu select "Who we are". Scroll down and you will see Dr. Suraj Kumar Saggars name listed along with a brief vita.
Agree. Quit flipping and watch the pps rise.
The problem is not with Charles. The problem is with the flippers. We need to uplist to bring in institutional investors to counteract the flippers from keeping us in the 3's and 4's. We all know who some of the major flippers are. This is disgusting to know we could be so much higher in pps than we are now. I believe one of the next PR's will be uplisting and will I believe we are close.
Eight Men Indicted for $114 Million Securities Fraud Scheme Orchestrated Through Social Media
IPF is now available for purchase on One Lavi. Successfully placed my first order.
Other mini-milestones could follow like Amazon, and Walmart, and CVS, etc. Chandra mentioned some 27 possible outlets back in March. These minis could sustain the pps, until a major PR such as an equity deal is released.
This to me looks like the beginning of the beginning of the tsunami.
Massive dilution by Matty.
So, there are actually NO NDA'S?? No Vet mab deal? No IPF?? This whole thing is acting true to character for a pinky. Are we now in the same category ast DE_N, VR_S and OPT_?Now I know what Chandra meant when he said this is the year of "consolidation".
At what point does a bio company's pps reflect future value?
All these subtle hints for the flippers. Duh.
My cup runner over.
All the "professional"micromanaging
only helps flippers for entry and exit points. True longs don't care about minute to minute play by play efforts even as sincere as they may be.
So, what about the multiple catalysts causing a tsunami? Multiple licencing, posible equity deal. So many possibilities. And don't forget the vet mabs around December.
Just went over 800,000 shares of my enzc babies that will grow into teenagers and then adulthood in the not too distant future. I believe we will be getting very significant checkmate news that will precipitate a "monumental" upswing in pps by eoy on Vet mabs involving the possibility of two major partnerships in US and Europe. GLTA
So, does that mean we wait at least one more year for the tsunami to begin??? Asking for a friend.
"Furthermore, publicly using or selling an invention more than 1 year prior to filing a patent application completely bars you from ever winning a patent on that invention."
Read the last paragraph ~More experiments are now needed to determine whether this monoclonal antibody can neutralize or kill different SARS-CoV-2 coronavirus variants and importantly, whether they also protect animals or humans against infection," Mabbott told DW.